Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group.
about
Epidemiological study air disaster in Amsterdam (ESADA): study designMaternal autoimmune diseases and immunologically induced embryonic and fetoplacental damageLow molecular weight heparin in immunological recurrent abortion--the incredible cureReal world experience with antiphospholipid antibody tests: how stable are results over time?Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV).Affinity purified human antiphospholipid antibodies bind normal term placenta.Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndromeLow-molecular-weight heparin for thrombophilia in pregnant women.Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus.Recent advances in the diagnosis of antiphospholipid syndrome.Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus.Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptides.Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor.Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant.Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome.Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus.The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome.Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatmentRenal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patientsThe clinical significance of antiphospholipid antibodies in patients without autoimmune disease.Autoantibodies and immunoglobulins in collagenous colitisRole of investigating thrombophilic disorders in young stroke.Phospholipid autoantibodies: time for a new immuno-assay?Antiphospholipid antibodies: method of detection.How to treat women with antiphospholipid antibodies in pregnancy?Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritisSystemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.Management of the obstetric antiphospholipid syndrome.African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV)Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.Antiphospholipid syndrome: association between laboratory tests and clinical practice.Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohortACP Broadsheet no 136: February 1993. Detection and importance of anticardiolipin antibodiesSystemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupusAntiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
P2860
Q24815725-902969E4-097F-478D-9467-C47C41EE7EC9Q28169065-ED34D587-E0AB-4E8D-A205-B1E32C98413CQ28195646-48E5244F-5754-4897-AC89-7ECBF1609061Q28218139-42659031-F251-4F38-9CC4-D6CD6F6671D5Q31129756-64263670-8885-40F7-8EF0-7E94F41B6544Q33330007-B7C202F1-C2DD-4FED-B62B-AE0F2C97B0F7Q33331690-5738BF04-6732-4BFF-858D-A4D72B6F5E1CQ33332833-D4F12927-9508-480E-BE2C-CE9BE9E2CA1CQ33339096-2E70F330-89DB-4439-8F73-DD4CED9A9F40Q33345276-A7C39D68-DFE8-49E1-A190-F450AD2FFF2DQ33350168-7DBE7F40-6A4D-400B-A496-A3A76212EDB2Q33363332-5F077177-FEF2-4E9D-B3A9-57AFA35DC97BQ33374070-AFC45289-05A4-4345-AA65-E98B93CAE2D2Q33380972-33A2D481-3364-4F44-8DCF-22FD9E9EC051Q33383811-38A0C994-470C-466C-9B92-14F23E4030A4Q33448450-27FDFC4C-78DC-4F03-95A6-B33FA54E6F02Q33455990-38C92709-9105-4A45-8578-F937D60C6581Q33488745-1AE2F846-0C83-4EFF-871D-EFBF209903E9Q33494551-4F0CF3F9-A333-43E0-AF3D-E9C929797BA7Q33497584-037FCA6D-80BE-40D2-869E-57F6EDC63A4BQ33555419-639233B1-75BF-4838-A201-91E963877F75Q33565796-0776B511-D554-4DA2-9D43-8264FFFCFB05Q33944778-25B0CA7F-E391-49C2-A0E8-19969606627CQ34151618-919A763E-A002-4980-A433-4CB2E3CB7CBCQ34409955-58E46AEA-BD69-45E1-BB6D-AB21C1224AE7Q34573328-A99E7649-DFFB-4BDD-87EC-11F9490805ADQ35008513-074C19C8-AC6C-4524-9E4F-C111DE4E7812Q35177113-467CC327-DB42-4BE5-9B74-B59269A2FD00Q35549772-71FCBC28-863A-4F3B-9FA7-D284B0EBEF76Q35552732-D3463140-70B5-4FE4-8326-D2104BCE3B4CQ35637240-56ECDCC8-5CE4-44E8-ABBB-029529A5234FQ35743192-433F4D1C-BC98-4B6B-B612-B8F4184BFD8EQ35953274-95E15272-BE7B-42DA-9A15-154548E393B8Q35977256-FA032CD0-FE97-404C-A4E9-F87CDD05B71EQ36030403-04B1C42C-FAB0-473F-8F63-26B17090B578Q36222874-326854F5-11CC-46E6-B1FE-F06FFD38F4C1Q37137299-534DA8F3-A2FB-4A63-A6FD-02B38D6C0ACCQ37232102-50ABB6D4-61AC-4596-BAD8-6158F8FD273FQ37327039-7BD369B2-9E9B-4204-92D5-37073A399FB3Q37358421-C921A2DF-0F0B-47A2-ABC1-197DEF9B8E8F
P2860
Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Special report. The Second Int ...... d Antibody Study (KAPS) group.
@en
Special report. The Second Int ...... ti-Phospholipid Antibody Study
@nl
type
label
Special report. The Second Int ...... d Antibody Study (KAPS) group.
@en
Special report. The Second Int ...... ti-Phospholipid Antibody Study
@nl
prefLabel
Special report. The Second Int ...... d Antibody Study (KAPS) group.
@en
Special report. The Second Int ...... ti-Phospholipid Antibody Study
@nl
P356
P1476
Special report. The Second Int ...... d Antibody Study (KAPS) group.
@en
P304
P356
10.1093/AJCP/94.4.476
P407
P577
1990-10-01T00:00:00Z